Richard Colling, Iciar Indave, Javier Del Aguilla, Ramon Cierco Jimenez, Fiona Campbell, Magdalena Chechlinska, Magdalena Kowalewska, Stefan Holdenrieder, Inga Trulson, Karolina Worf, Marina Pollán, Elena Plans-Beriso, Beatriz Pérez-Gómez, Oana Craciun, Ester García-Ovejero, Irmina Maria Michalek, Kateryna Maslova, Grzegorz Rymkiewicz, Joanna Didkowska, Puay Hoon Tan, Nur Diyana Bte Md Nasir, Nickolas Myles, Christine Giesen, Gabrielle Goldman-Lévy, Dilani Lokuhetty, Ian A Cree
Evidence-based medicine (EBM) can be unfamiliar territory for those working in tumor pathology research and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, endorsed by the WHO International Agency for Research on Cancer's (IARC) International Collaboration for Cancer Classification and Research (IC3 R), we aim to help pathologists and researchers to understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these...
May 17, 2024: Modern Pathology